Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1

Conditions

Post-traumatic Stress Symptoms 1Ovarian Neoplasms 1Neoplasms 1Frailty 1Endometrial Neoplasms 1Depression 1Anxiety Disorders 1

Interventions

Magnetic Resonance Spectroscopy 262Specimen Handling 253pembrolizumab 230Cyclophosphamide 216Radiotherapy 204Nivolumab 168Cisplatin 161Carboplatin 145Biopsy 144Radiosurgery 128fludarabine 123Blood Specimen Collection 116Gemcitabine 111Paclitaxel 107Surveys and Questionnaires 106Standard of Care 102venetoclax 94Dexamethasone 93Bevacizumab 92Radiation 87Rituximab 81Capecitabine 80Cytarabine 79Oxaliplatin 77Drug Therapy 75Doxorubicin 75Ipilimumab 73durvalumab 70fludarabine phosphate 69atezolizumab 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Psychosocial Intervention × 90 days × Clear all
NCT07582666 2026-05-13

CAERES

UniDistance Suisse

Phase NA Completed
32 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT07160933 2026-03-31

Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivors of Cancer

Massachusetts General Hospital

Phase NA Not yet recruiting
80 enrolled

Post-traumatic Stress Symptoms

NCT04789694 2026-03-19

PHOCUS

Charles University, Czech Republic

Phase 3 Recruiting
64 enrolled
Gynecologic

Frailty, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡